glp 1 and restless leg syndrome Does Tirzepatide Cause Legs Syndrome? tirzepatide restless leg syndrome Mounjaro

[DOI] [PMC free article] [PubMed] [Google Scholar] 9.Berenbaum F

This is echoed in a clinical practice discussion on addressing overweight and obesity, which reviews trial-level weight loss of around 1520% in major Phase 3 trials with current GLP-1 and dual-agonist agents and improvements in sleep apnea, fatty liver disease, and cardiovascular risk markers

Taste perception and implicit attitude toward sweet related to body mass index and soft drink supplementation

is also a consultant for Netdoktor and has served as principal investigator in relation to the development of drugs for the treatment of type 2 diabetes and obesity in collaboration with Novo Nordisk and Bayer, with funds paid to the institution where he is employed, with no personal fee and with no relation to the work reported in this article